The association between sedentary behavior and sarcopenia among adults aged ≥65 years in low-and middle-income countries by Smith, Lee et al.
International  Journal  of
Environmental Research
and Public Health
Article
The Association Between Sedentary Behavior and
Sarcopenia Among Adults Aged ≥65 Years in Low-
and Middle-Income Countries
Lee Smith 1,*, Mark Tully 2 , Louis Jacob 3, Nicole Blackburn 4, Deepti Adlakha 5 ,
Paolo Caserotti 6, Pinar Soysal 7, Nicola Veronese 8 , Guillermo F. López Sánchez 9 ,
Davy Vancampfort 10 and Ai Koyanagi 11,12
1 The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge CB1 1PT, UK
2 Institute of Mental Health Sciences, School of Health Sciences, Ulster University, Newtownabbey BT37 0QB,
UK; m.tully@ulster.ac.uk
3 Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, 78180 Montigny-le-Bretonneux,
France; louis.jacob.contacts@gmail.com
4 Institute of Nursing and Health Research, School of Health Sciences, Ulster University,
Newtownabbey BT37 0QB, UK; ne.blackburn@ulster.ac.uk
5 School of Natural and Built Environment, Queen’s University Belfast, Belfast BT9 5AG, UK;
D.Adlakha@qub.ac.uk
6 Center for Active and Healthy Ageing, Department of Sports Science and Clinical Biomechanics, Faculty of
Health Sciences, University of Southern Denmark, 5230 Odense, Denmark; pcaserotti@health.sdu.dk
7 Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, 34093 Istanbul, Turkey;
dr.pinarsoysal@hotmail.com
8 Geriatric Unit, Deptartment of Internal Medicine and Geriatrics, University of Palermo, 90133 Palermo, Italy;
ilmannato@gmail.com
9 Faculty of Sport Sciences, University of Murcia, 30720 Murcia, Spain; gfls@um.es
10 KU Leuven Department of Rehabilitation Sciences, 3000 Leuven, Belgium; davy.vancampfort@kuleuven.be
11 Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, 08830 Barcelona, Spain;
koyanagi1117@gmail.com
12 ICREA, Pg. Lluis Companys 23, 08010 Barcelona, Spain
* Correspondence: Lee.Smith@anglia.ac.uk
Received: 7 February 2020; Accepted: 4 March 2020; Published: 5 March 2020


Abstract: The present study aimed to assess the association between sedentary behavior and
sarcopenia among adults aged ≥65 years. Cross-sectional data from the Study on Global Ageing
and Adult Health were analyzed. Sarcopenia was defined as having low skeletal muscle mass
and either a slow gait speed or a weak handgrip strength. Self-reported sedentary behavior was
assessed as a continuous variable (hours per day) and also as a categorical variable (0–<4, 4–<8, 8–<11,
≥11 hours/day). Multivariable logistic regression was conducted to assess the association between
sedentary behavior and sarcopenia. Analyses using the overall sample and country-wise samples
were conducted. A total of 14,585 participants aged ≥65 years were included in the analysis. Their
mean age was 72.6 (standard deviation, 11.5) years and 55% were females. Compared to sedentary
behavior of 0–<4 hours/day, ≥11 hours/day was significantly associated with 2.14 (95% CI = 1.06–4.33)
times higher odds for sarcopenia. The country-wise analysis showed that overall, a one-hour increase
in sedentary behavior per day was associated with 1.06 (95% CI = 1.04–1.10) times higher odds for
sarcopenia, while the level of between-country heterogeneity was low (I2 = 12.9%). Public health and
healthcare practitioners may wish to target reductions in sedentary behavior to aid in the prevention
of sarcopenia in older adults.
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1. Introduction
Sarcopenia may be defined as “age-related muscle loss, affecting a combination of appendicular
muscle mass, muscle strength, and/or physical performance measures” [1]. The prevalence of sarcopenia
is high in older adults. For example, a recent meta-analysis suggested that sarcopenia prevalence
in older adults is approximately 10% [2]. Importantly, sarcopenia has been shown to be associated
with several adverse health outcomes in older people. In a recent umbrella review with integrated
meta-analyses on the association between sarcopenia with other medical conditions in older adults,
it was found that sarcopenia was associated with premature mortality, disability, and falls [3]. Moreover,
other research has suggested that sarcopenia is associated with a significantly higher proportion of
problems relating to several dimensions of quality of life [4]. Owing to the relatively high prevalence
of sarcopenia and the associated adverse health outcomes, research is needed to identify modifiable
risk factors of the condition to inform targeted interventions.
There is a large body of literature to suggest that participation in physical activity in older adults
aids in the prevention of sarcopenia. Indeed, in one systematic review of 10 studies, it was concluded
that participation in physical activity is an effective protective strategy for sarcopenia in geriatric
populations [5]. While there is a relatively large body of literature on the relationship between physical
activity and sarcopenia, less is known about the relationship between sedentary behavior (sitting on the
opposing end of the energy expenditure continuum to physical activity) and sarcopenia. It is plausible
that sedentary behavior is associated with sarcopenia, as sedentary behavior has been shown to be
associated with higher levels of deep adipose tissue and visceral adiposity that results in a catabolic
effect on muscle by promoting protein degradation [6]. Importantly, older adults spend the majority of
their waking day in sedentary activities, as opposed to being physically active [7]. In one cross-sectional
study focusing on 1286 British men, it was found that sedentary time was associated with an increased
risk of sarcopenic obesity independent of levels of moderate-to-vigorous physical activity (relative
risk (RR): 1.18, 95% CI 0.99–1.40) [8]. In another small study of 162 men and women aged 60 to 86
years residing in Australia, it was concluded that higher levels of sedentary behavior were associated
with sarcopenia. Specifically, for each one-hour increment in sedentary time, the risk of sarcopenia
increased by 33% [9]. Another cross-sectional study of 102 older Australian adults concluded that
sitting time (odds ratio (OR) 1.18, 95% CI 1.00–1.39) was marginally predictive of sarcopenia [10]. While
other literature exists on the relationship between sedentary behavior and physical function (e.g., grip
strength) [11], to our knowledge, no other literature has examined the relationship between sedentary
behavior and sarcopenia in older adults. The existing literature is limited due to small sample sizes,
with some studies focusing exclusively on men, and all have been carried out in a single high-income
country (HIC).
Given that ageing is occurring more rapidly in low- and middle- income countries (LMICs)
compared to HICs [12], while there are markedly different socio-cultural norms, occupational and
family structures, societal norms, environmental features (e.g., built form, housing types), and methods
of transportation in LMICs, there is a need for context-specific research in settings [13]. Moreover,
multicountry studies are important, as they provide a platform to investigate between-country
differences utilizing standardized data.
Given the previously limited literature and its focus on HIC utilizing small and potentially
unrepresentative samples, the aim of this study was to assess the association between sedentary
behavior and sarcopenia among adults aged ≥65 years from six LMICs (China, Ghana, India, Mexico,
Russia, and South Africa) using nationally representative datasets. These countries broadly represent
different geographical locations and levels of socio-economic and demographic transition.
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2. Methods
2.1. The Survey
Data from the Study on Global Ageing and Adult Health (SAGE) were analyzed. These data are
publicly available [14]. This survey was undertaken in China, Ghana, India, Mexico, Russia, and South
Africa between 2007 and 2010. When the survey was conducted, and according to the World Bank
classification, Ghana was the only low-income country, and China and India were lower middle-income
countries. However, it should be noted that China became an upper middle-income country in 2010.
All other countries were classed as upper middle-income.
The survey protocol has been published in detail elsewhere [15]. Briefly, a multistage, clustered
sampling design method was employed in order to obtain nationally representative samples.
Participants were aged ≥18 years and oversampling of those aged ≥50 years was employed. A standard
questionnaire was used by trained interviewers and face-to-face interviews were conducted. To ensure
comparability between countries, standard translation procedures were undertaken. The survey
response rates were: China, 93%; Ghana, 81%; India, 68%; Mexico, 53%; Russia, 83%; and South Africa,
75%. As reported by the United Nations Statistical Division, sampling weights were developed in
order to adjust for population structure. Ethical approval was obtained from the WHO Ethical Review
Committee and local ethics research review boards. Written informed consent was obtained from all
participants. This present analyses utilized existing data that is publicly available online; thus, there
are no ethical concerns in terms of its use for secondary data analysis.
2.2. Sarcopenia
Following the criteria used in a previous publication using the same dataset [16], sarcopenia was
defined as having low skeletal muscle mass (SMM) confirmed by lower skeletal mass index (SMI)
and either a weak handgrip strength or a slow gait speed [17]. Skeletal muscle mass (SMM) was
calculated as the appendicular skeletal muscle mass (ASM) based on the equation proposed by Lee and
colleagues: ASM = 0.244 * weight + 7.8 * height + 6.6 * sex–0.098 * age + race–3.3 (where female = 0
and male = 1; race = 0 (White and Hispanic), race = 1.9 (Black) and race = −1.6 (Asian)) [18]. Utilizing
measured weight and height to create a skeletal muscle mass index (SMI), the ASM was further divided
by BMI [19]. Low SMM was defined as the lowest quintile of the SMI based on sex-stratified values.
To assess gait speed, a 4 m timed walk was carried out by asking the participant to safely walk at
a rapid pace. The time to completion of the 4 m walk was recorded by the interviewer. The lowest
quintile of walking speed based on height, age, and sex-stratified values was referred to as slow gait
speed [20,21]. Handgrip strengths <30 kg for men and <20 kg for women using the average value of
the two handgrip measurements of the dominant hand were defined as “weak” [22].
2.3. Sedentary Behavior
To measure sedentary behavior, participants were asked to state the total time they usually spent
(expressed in minutes per day) sitting or reclining, including at home, at work, getting to and from
places, and with friends (e.g., sitting with friends, travelling in car, bus, train, reading, sitting at a desk,
watching television, or playing cards). The present measure excluded sleeping time. This single item is
derived from the Global Physical Activity questionnaire (GPAQ) [23]. The GPAQ is a suitable and
acceptable instrument for monitoring sedentary behavior in population health surveillance systems [24].
Sedentary behavior was assessed as a continuous variable (hours per day) and as a categorical variable
(0–<4, 4–<8, 8–<11, ≥11 hours/day) [25].
2.4. Covariates
The covariates used for adjustment were selected based on past literature [8,9,26] and included age,
sex, highest education achieved (primary, secondary, tertiary), wealth quintiles based on country-specific
income, physical activity, current smoking, current drinking (alcohol consumption in the past 30 days),
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number of chronic physical conditions, and BMI (<18.5, 18.5–24.9, 25.0–29.9, ≥30 kg/m2). Levels of
physical activity were assessed with the GPAQ and were classified as low, moderate, and high based
on conventional cut-offs [24]. We included 10 chronic physical conditions (angina pectoris, arthritis,
asthma, cataract, chronic lung disease, diabetes mellitus, edentulism, hearing problems, hypertension,
stroke), assessed according to self-report of diagnosis, symptoms, interviewer observation, and blood
pressure measurement (see Supplementary Table S1 for details). The total number of chronic conditions
was summed for each individual and categorized as 0, 1, or ≥2.
2.5. Statistical Analysis
Analyses were performed with Stata version 14.1 (Stata Corp LP, College Station, TX, USA).
The analysis was restricted to those aged ≥65 years, as sarcopenia is an age-related condition.
Multivariable logistic regression analysis was conducted to assess the association between sedentary
behavior (exposure) and sarcopenia (outcome). Analyses using the overall sample and country-wise
samples were conducted. We used the categorical variable of sedentary behavior (0–<4, 4–<8, 8–<11,
≥11 hours/day) for the analysis using the overall sample, while we used the continuous variable of
sedentary behavior (hours/day) for the country-wise analysis. We also conducted a test for trend in
the analysis using the overall sample by including the categorical sedentary behavior variable in the
model as a continuous variable.
In order to assess the between-country heterogeneity, the Higgins’s I2 based on estimates from
each country was calculated. The Higgins’s I2 represents the degree of heterogeneity that is not
explained by sampling error, with a value of less than 40% being negligible and 40%–60% representing
moderate heterogeneity [27]. Fixed-effect meta-analyses were used to obtain pooled estimates.
All models were adjusted for age, sex, education, wealth, physical activity, smoking, alcohol
consumption, number of chronic conditions, and BMI. For the analysis using the overall sample,
adjustment for country was also done by including dummy variables for each country in the model,
as in previous SAGE publications. In all analyses, the sample weighting and the complex study design
were corrected. Results from the regression analyses are presented as odds ratios (ORs) with 95%
confidence intervals (CIs). Statistical significance was set at p < 0.05.
3. Results
A total of 14,585 participants aged ≥65 years were included in the analysis (China, n = 5360; Ghana,
n = 1975; India, n = 2441; Mexico, n = 1375; Russia, n = 1950; South Africa, n = 1484). The sample
characteristics are provided in Table 1. The mean age was 72.6 (standard deviation [SD], 11.5) and
55% were female. The prevalence of low physical activity was 39.6%, while that of current smoking
and alcohol consumption were 29.3% and 13.9%, respectively. Overall, 89.6% had at least one chronic
condition, while 10.4% had obesity. The prevalence of sarcopenia was 15.7%, while the percentage
of those who engaged in 0–<4, 4–<8, 8–<11, and ≥11 hours/day of sedentary behavior was 43.3%,
40.8%, 11.8%, and 4.1%, respectively. The prevalence of sarcopenia increased with increasing time
spent in sedentary behavior (Figure 1). Specifically, this increased from 13.1% for 0–<4 hours/day of
sedentary behavior to 28.1% for ≥11 hours. This was confirmed in the adjusted analysis, where there
was a significant increasing trend (p = 0.006) for the odds for sarcopenia with increasing levels of
sedentary behavior (Table 2). Compared to sedentary behavior of 0–<4 hours/day, ≥11 hours/day was
significantly associated with 2.14 (95% CI = 1.06–4.33) times higher odds for sarcopenia. Other factors
that were significantly associated with sarcopenia included male sex, lower socioeconomic status,
and higher BMI. Physical activity was not significantly associated with sarcopenia. The country-wise
analysis showed that overall, a one-hour increase in sedentary behavior per day is associated with a 1.06
(95% CI = 1.04–1.10) times higher odds for sarcopenia, and the level of between-country heterogeneity
was low (I2 = 12.9%) (Figure 2). The strongest association was observed in India (OR = 1.09; 95%
CI = 1.03–1.16).
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Table 1. Sample characteristics.
Characteristic
Age (years) Mean (standard deviation) 72.6 (11.5)
Sex Female 55.0
Male 45.0
Education Primary 63.7
Secondary 29.9
Tertiary 6.4
Wealth Poorest 21.7
Poorer 21.0
Middle 20.4
Richer 17.5
Richest 19.4
Physical activity High 35.2
Moderate 25.2
Low 39.6
Current smoker No 70.7
Yes 29.3
Current drinker No 86.1
Yes 13.9
No. of chronic conditions 0 10.4
1 22.3
≥2 67.2
Body mass index (kg/m2) 18.5-24.9 46.4
25.0-29.9 23.9
≥30.0 10.4
<18.5 19.3
Data are % unless otherwise stated.
Figure 1. Prevalence of sarcopenia by time spent in sedentary behavior. Bars denote 95% confidence
intervals.
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Table 2. Association of sedentary behavior and covariates with sarcopenia, estimated by multivariable
logistic regression.
Characteristic OR 95% CI p-Value
Sedentary behavior a 0–<4 1.00
(hours/day) 4–<8 1.18 [0.94,1.48] 0.148
8–<11 1.44 [1.00,2.10] 0.053
≥11 2.14 [1.06,4.33] 0.033
Age (years) 1.13 [1.11,1.15] <0.001
Sex Female 1.00
Male 1.25 [1.02,1.54] 0.031
Education Primary 1.00
Secondary 0.71 [0.53,0.94] 0.018
Tertiary 0.68 [0.45,1.04] 0.079
Wealth Poorest 1.00
Poorer 0.64 [0.50,0.82] 0.001
Middle 0.53 [0.38,0.74] <0.001
Richer 0.49 [0.37,0.65] <0.001
Richest 0.33 [0.24,0.45] <0.001
Physical activity High 1.00
Moderate 1.10 [0.90,1.34] 0.343
Low 1.20 [0.95,1.53] 0.129
Current smoker No 1.00
Yes 0.91 [0.70,1.17] 0.456
Current drinker No 1.00
Yes 0.88 [0.62,1.25] 0.467
No. of chronic
conditions 0 1.00
1 1.07 [0.73,1.57] 0.718
≥2 1.19 [0.81,1.76] 0.377
Body mass index (kg/m2) 18.5–24.9 1.00
25.0–29.9 1.34 [1.09,1.65] 0.006
≥30.0 2.52 [1.82,3.49] <0.001
<18.5 0.60 [0.42,0.85] 0.004
Abbreviation: OR, odds ratio; CI, confidence interval. Model is mutually adjusted for all variables in the Table and
country. a Significant test for trend (p = 0.006).
Int. J. Environ. Res. Public Health 2020, 17, 1708 7 of 10
Figure 2. Country-wise association between sedentary behavior (per one hour increase/day) and
sarcopenia, estimated by multivariable logistic regression. Abbreviations: OR, odds ratio; CI, confidence
interval. Models are adjusted for age, sex, education, wealth, physical activity, smoking, alcohol
consumption, chronic conditions, and body mass index. Overall estimate was obtained by meta-analysis
with fixed effects.
4. Discussion
The present study, in a large sample of older adults from six LMICs, found that the overall
prevalence of sarcopenia was 15.7%. There was a significant increasing trend for the odds for
sarcopenia with increasing levels of sedentary behavior. Moreover, compared to the sedentary behavior
group of 0–<4 hours/day, ≥11 hours/day was associated with a 2.14 times higher odds for sarcopenia,
and country-wise analysis showed that overall, a one-hour increase in sedentary behavior per day was
associated with a 1.06 times higher odds for sarcopenia. Taken together, these findings suggest that
higher levels of sedentary time are associated with higher levels of sarcopenia.
The present findings support previous work that also found that higher levels of sedentary
behavior were associated with higher odds or risk of sarcopenia [8–10,26]. However, it should be
noted here that previous studies show a slightly higher risk between sedentary time and sarcopenia.
This slight difference in findings may be owing to previous work consisting of small and potentially
unrepresentative samples and solely focusing on HICs. The present findings add to this literature
by showing that such an association exists in a large sample of both men and women from LMICs
using nationally representative datasets. Considering sarcopenia has been shown to be associated with
premature mortality, disability, falls, and lower quality of life [3,4], the present finding that a one-hour
increase in sedentary behavior per day was associated with 1.06 times higher odds for sarcopenia is
meaningful, and sedentary behaviour reduction interventions may provide another avenue to prevent
against sarcopenia.
Some plausible pathways may explain the observed association between sedentary behavior
and sarcopenia. First, it is possible that an increase in sedentary time may displace time in physical
Int. J. Environ. Res. Public Health 2020, 17, 1708 8 of 10
activity, and indeed higher levels of physical activity have been shown to be associated with lower
levels of sarcopenia [5]. In support, in one study utilizing isotemporal substitution, it was found
that an increase in moderate-to-vigorous physical activity replacing sedentary behavior and light
physical activity were associated with a reduction in sarcopenia prevalence [26]. Therefore, it is
possible that the association between sedentary behavior and sarcopenia observed in the present study
is the reverse of the association between light physical activity and sarcopenia. Next, higher levels
of sedentary behavior have been shown to be associated with higher levels of liver adiposity and
visceral/subcutaneous abdominal fat ratio [6]. Indeed, deep adipose tissue and visceral adiposity
have been shown to be associated with an increase in pro-inflammatory cytokines and a decrease in
anti-inflammatory markers [28,29], which can have a catabolic effect on muscle by promoting protein
degradation [30]. Finally, sedentary behaviour, per se, has been shown to be associated with higher
levels of chronic low-grade inflammation [31], and thus is potentially directly associated with a higher
risk of sarcopenia [32].
In our study, physical activity was not significantly associated with sarcopenia, in contrast to
what has been found in most previous studies [33]. This may be due to the fact that previous studies
have not considered sedentary behavior in their analysis. Specifically, when sedentary behavior was
removed from the model, low physical activity (vs. high physical activity) was significantly associated
with 1.29 (95% CI = 1.02–1.61) times higher odds for sarcopenia in our study. However, this was
no longer significant when sedentary behavior was included in the model. Thus, future studies on
physical activity and sarcopenia should take sedentary behavior into account, as it is possible that it is
more strongly associated with sarcopenia than physical activity.
Findings highlight the need for sedentary behavior reduction in older adults to aid in the
prevention against sarcopenia. An important part of this process will involve development of culturally
specific supports, interventions, and strategies that are tailored to the social norms, contextual factors,
and realities of public spaces and infrastructure, as well as issues of equity and safety in LMICs.
The clear strengths of this study include its large nationally representative sample of older people
around the world, data collection having been carried out across multiple LMICs, and the inclusion of
both men and women. However, findings from this study must be interpreted in light of its limitations.
First, the survey is cross-sectional, and thus it is not possible to infer whether sedentary behavior is
driving sarcopenia or if individuals become sarcopenic and then exhibit higher levels of sedentary
behavior. The association is likely to be bidirectional. Future research of a longitudinal nature is
required to test these assumptions. In addition, estimates of ASM were calculated using population
equations but not direct assessment. However, this formula is validated in diverse populations against
gold standard methods, such as dual-energy X-ray absorptiometry and magnetic resonance imaging;
good concordance rates have been reported [16]. Finally, the survey did not include a robust dietary
assessment, and thus the role of diet could not be considered in the investigated associations.
5. Conclusions
In conclusion, in the present large multicontinent study, higher levels of sedentary behavior were
found to be associated with higher levels of sarcopenia. Public health and healthcare practitioners may
want to target reductions in sedentary behavior to aid in the prevention of sarcopenia in older adults.
However, before concrete recommendations can be provided, future research utilizing a longitudinal
design is required. Moreover, future observational research utilizing nationally representative samples
from HICs is also warranted.
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